Picture of Biotechnology Assets SA logo

BST — Biotechnology Assets SA News Story

0.000.00%
es flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Bionaturis comments on FY 2015 guidance, updates business plan

Sept 21 (Reuters) - Bioorganic Research and Services SA 
(Bionaturis)  BNT.MC : 
    * Sees FY 2015 net sales at 1.3 million euros ($1.46 
million), sees FY 2015 net sales of Bionaturis and Target after 
merger at 9.3 million euros 
    * Sees FY 2015 EBITDA at 92,000 euros, FY 2015 EBITDA net 
sales of Bionaturis and Target after merger at 2.0 million euros 
    * Says the target is a contract manufacturing organization 
which produces pharmaceutical products and nutraceuticals, 
provides services 
    * With the mergers sees to diversify products, clients, 
sectors, decrease risk, gain critical mass to obtain financing 
 
     
Source text: http://bit.ly/1KGVcrv 
     
Further company coverage:  BNT.MC  
 
($1 = 0.8924 euros) 
 
 (Gdynia Newsroom) 
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))

Recent news on Biotechnology Assets SA

See all news